One Stoke Therapeutics (STOK) holder reports 4.82 million shares but zero voting power.
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
FMR LLC has reported a 7.5% beneficial ownership stake in Stoke Therapeutics (STOK), holding 4,820,462 shares, with sole voting power over 4,819,851 shares. Separately, Abigail P. Johnson is listed with the same beneficial ownership and sole dispositive power, but explicitly states zero sole or shared voting power over the shares.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.